{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:39:27Z","timestamp":1795041567360,"version":"4.10.2"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2020\/37\/B\/ NZ5\/00366"],"award-info":[{"award-number":["2020\/37\/B\/ NZ5\/00366"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Trimethylamine oxide (TMAO) is a biomarker in cardiovascular and renal diseases. TMAO originates from the oxidation of trimethylamine (TMA), a product of gut microbiota and manufacturing industries-derived pollutant, by flavin monooxygenases (FMOs). The effect of chronic exposure to TMA on cardiovascular and renal systems is\u00a0undetermined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Metabolic, hemodynamic, echocardiographic, biochemical and histopathological evaluations were performed in 12-week-old male SPRD rats receiving water (controls) or TMA (200 or 500\u00a0\u00b5M\/day) in water for 18\u00a0weeks. TMA and TMAO levels, the expression of FMOs and renin-angiotensin system (RAS) genes were evaluated in various tissues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In comparison to controls, rats receiving high dose of TMA had significantly increased arterial systolic blood pressure (126.3\u2009\u00b1\u200911.4 vs 151.2\u2009\u00b1\u200919.9\u00a0mmHg; P\u2009=\u20090.01), urine protein to\u00a0creatinine ratio (1.6 (1.5;\u00a02.8) vs 3.4 (3.3;\u00a04.2); P\u2009=\u20090.01), urine KIM-1 levels (2338.3\u2009\u00b1\u2009732.0 vs. 3519.0\u2009\u00b1\u2009953.0\u00a0pg\/mL; P\u2009=\u20090.01), and hypertrophy of the tunica media of\u00a0arteries and arterioles (36.61\u2009\u00b1\u20090.15 vs 45.05\u2009\u00b1\u20092.90\u00a0\u00b5m, P\u2009=\u20090.001 and 18.44\u2009\u00b1\u20090.62 vs\u00a023.79\u2009\u00b1\u20092.60\u00a0\u00b5m, P\u2009=\u20090.006; respectively). Mild degeneration of renal bodies with glomerulosclerosis was also observed. There was no significant difference between the three groups in body weight, water-electrolyte balance, echocardiographic parameters and RAS expression. TMA groups had marginally increased 24\u00a0h TMA urine excretion, whereas serum levels and 24\u00a0h TMAO urine excretion were increased up to 24-fold, and significantly increased TMAO levels in the liver, kidneys and heart. TMA groups had lower FMOs expression in the kidneys.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Chronic exposure to TMA increases blood pressure and increases markers of\u00a0kidney damage, including proteinuria and KIM-1. TMA is rapidly oxidized to TMAO in\u00a0rats, which may limit the toxic effects of TMA on other organs.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12967-022-03687-y","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T21:02:47Z","timestamp":1665867767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats"],"prefix":"10.1186","volume":"20","author":[{"given":"Klaudia M.","family":"Maksymiuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Szudzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gawry\u015b-Kopczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksymilian","family":"Onyszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Samborowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabella","family":"Mogilnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-8284","authenticated-orcid":false,"given":"Marcin","family":"Ufnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"issue":"6","key":"3687_CR1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","volume":"20","author":"R Vanholder","year":"2005","unstructured":"Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N, et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005;20(6):1048\u201356.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"3687_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00134-008-1017-8","volume":"34","author":"C Ronco","year":"2008","unstructured":"Ronco C, House AA, Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med. 2008;34(5):957\u201362.","journal-title":"Intensive Care Med"},{"issue":"2","key":"3687_CR3","first-page":"250","volume":"35","author":"F Nanto-Hara","year":"2020","unstructured":"Nanto-Hara F, Kanemitsu Y, Fukuda S, Kikuchi K, Asaji K, Saigusa D, et al. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease. Nephrol Dial Transplant. 2020;35(2):250\u201364.","journal-title":"Nephrol Dial Transplant"},{"key":"3687_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.751380","volume":"12","author":"D Zou","year":"2021","unstructured":"Zou D, Li Y, Sun G. Attenuation of circulating trimethylamine N-oxide prevents the progression of cardiac and renal dysfunction in a rat model of chronic cardiorenal syndrome. Front Pharmacol. 2021;12: 751380.","journal-title":"Front Pharmacol"},{"issue":"10","key":"3687_CR5","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1253\/circj.CJ-15-0749","volume":"79","author":"S Lekawanvijit","year":"2015","unstructured":"Lekawanvijit S. Role of gut-derived protein-bound uremic toxins in cardiorenal syndrome and potential treatment modalities. Circ J. 2015;79(10):2088\u201397.","journal-title":"Circ J"},{"issue":"6","key":"3687_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jacc.2013.04.070","volume":"62","author":"FH Verbrugge","year":"2013","unstructured":"Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WH, et al. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol. 2013;62(6):485\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3687_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0925-4439(91)90046-C","volume":"1096","author":"JD Bell","year":"1991","unstructured":"Bell JD, Lee JA, Lee HA, Sadler PJ, Wilkie DR, Woodham RH. Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide. Biochim Biophys Acta. 1991;1096(2):101\u20137.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"3687_CR8","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/jcm9020336","volume":"9","author":"CN Hsu","year":"2020","unstructured":"Hsu CN, Chang-Chien GP, Lin S, Hou CY, Lu PC, Tain YL. Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease. J Clin Med. 2020;9(2):336.","journal-title":"J Clin Med."},{"issue":"8","key":"3687_CR9","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1681\/ASN.2012101006","volume":"24","author":"EP Rhee","year":"2013","unstructured":"Rhee EP, Clish CB, Ghorbani A, Larson MG, Elmariah S, McCabe E, et al. A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol. 2013;24(8):1330\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3687_CR10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WH Tang","year":"2015","unstructured":"Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116(3):448\u201355.","journal-title":"Circ Res"},{"issue":"5","key":"3687_CR11","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/ndt\/gfk056","volume":"21","author":"MA Bain","year":"2006","unstructured":"Bain MA, Faull R, Fornasini G, Milne RW, Evans AM. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant. 2006;21(5):1300\u20134.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"3687_CR12","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576\u201385.","journal-title":"Nat Med"},{"issue":"7341","key":"3687_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u201363.","journal-title":"Nature"},{"issue":"14","key":"3687_CR14","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","volume":"35","author":"Z Wang","year":"2014","unstructured":"Wang Z, Tang WH, Buffa JA, Fu X, Britt EB, Koeth RA, et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur Heart J. 2014;35(14):904\u201310.","journal-title":"Eur Heart J"},{"key":"3687_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yjmcc.2020.12.001","volume":"152","author":"P Mamic","year":"2021","unstructured":"Mamic P, Chaikijurajai T, Tang WHW. Gut microbiome\u2014a potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review. J Mol Cell Cardiol. 2021;152:105\u201317.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"3687_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41598-020-80063-0","volume":"11","author":"W Zhang","year":"2021","unstructured":"Zhang W, Miikeda A, Zuckerman J, Jia X, Charugundla S, Zhou Z, et al. Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice. Sci Rep. 2021;11(1):518.","journal-title":"Sci Rep"},{"issue":"1","key":"3687_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/advances\/nmz064","volume":"11","author":"X Ge","year":"2020","unstructured":"Ge X, Zheng L, Zhuang R, Yu P, Xu Z, Liu G, et al. The gut microbial metabolite trimethylamine N-oxide and hypertension risk: a systematic review and dose-response meta-analysis. Adv Nutr. 2020;11(1):66\u201376.","journal-title":"Adv Nutr"},{"key":"3687_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102115","volume":"46","author":"S Jiang","year":"2021","unstructured":"Jiang S, Shui Y, Cui Y, Tang C, Wang X, Qiu X, et al. Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II-induced hypertension. Redox Biol. 2021;46: 102115.","journal-title":"Redox Biol"},{"issue":"2","key":"3687_CR19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jn\/nxz214","volume":"150","author":"P Aldana-Hernandez","year":"2020","unstructured":"Aldana-Hernandez P, Leonard KA, Zhao YY, Curtis JM, Field CJ, Jacobs RL. Dietary choline or trimethylamine N-oxide supplementation does not influence atherosclerosis development in Ldlr-\/- and Apoe-\/- male mice. J Nutr. 2020;150(2):249\u201355.","journal-title":"J Nutr"},{"key":"3687_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.57028","author":"M Gawrys-Kopczynska","year":"2020","unstructured":"Gawrys-Kopczynska M, Konop M, Maksymiuk K, Kraszewska K, Derzsi L, Sozanski K, et al. TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats. Elife. 2020. https:\/\/doi.org\/10.7554\/eLife.57028.","journal-title":"Elife"},{"issue":"6","key":"3687_CR21","doi-asserted-by":"publisher","first-page":"H1805","DOI":"10.1152\/ajpheart.00536.2018","volume":"315","author":"T Huc","year":"2018","unstructured":"Huc T, Drapala A, Gawrys M, Konop M, Bielinska K, Zaorska E, et al. Chronic, low-dose TMAO treatment reduces diastolic dysfunction and heart fibrosis in hypertensive rats. Am J Physiol Heart Circ Physiol. 2018;315(6):H1805\u201320.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"14","key":"3687_CR22","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/cvr\/cvz231","volume":"115","author":"K Jaworska","year":"2019","unstructured":"Jaworska K, Bielinska K, Gawrys-Kopczynska M, Ufnal M. TMA (trimethylamine), but not its oxide TMAO (trimethylamine-oxide), exerts haemodynamic effects: implications for interpretation of cardiovascular actions of gut microbiome. Cardiovasc Res. 2019;115(14):1948\u20139.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"3687_CR23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/toxins11090490","volume":"11","author":"K Jaworska","year":"2019","unstructured":"Jaworska K, Hering D, Mosieniak G, Bielak-Zmijewska A, Pilz M, Konwerski M, et al. TMA, a forgotten uremic toxin, but not TMAO, is involved in cardiovascular pathology. Toxins (Basel). 2019;11(9):490.","journal-title":"Toxins (Basel)"},{"issue":"7","key":"3687_CR24","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/gerona\/glz181","volume":"75","author":"K Jaworska","year":"2020","unstructured":"Jaworska K, Konop M, Hutsch T, Perlejewski K, Radkowski M, Grochowska M, et al. Trimethylamine but not trimethylamine oxide increases with age in rat plasma and affects smooth muscle cells viability. J Gerontol A Biol Sci Med Sci. 2020;75(7):1276\u201383.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"11\u201312","key":"3687_CR25","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.nut.2015.05.006","volume":"31","author":"M Ufnal","year":"2015","unstructured":"Ufnal M, Zadlo A, Ostaszewski R. TMAO: a small molecule of great expectations. Nutrition. 2015;31(11\u201312):1317\u201323.","journal-title":"Nutrition"},{"key":"3687_CR26","unstructured":"Pospischil E JG, Nielsen GD, Papameletiou D, Klein CL. SCOEL\/REC\/179 Trimethylamine. Publ Sci Comm Occup Expo Lim Eur Union. 2017."},{"key":"3687_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev.pharmtox.46.120604.141043","volume":"46","author":"JR Cashman","year":"2006","unstructured":"Cashman JR, Zhang J. Human flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol. 2006;46:65\u2013100.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"3687_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJM197707212970303","volume":"297","author":"ML Simenhoff","year":"1977","unstructured":"Simenhoff ML, Burke JF, Saukkonen JJ, Ordinario AT, Doty R. Biochemical profile or uremic breath. N Engl J Med. 1977;297(3):132\u20135.","journal-title":"N Engl J Med"},{"issue":"2","key":"3687_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000083709","volume":"18","author":"JW Fluhr","year":"2005","unstructured":"Fluhr JW, Kelterer D, Fuchs S, Kaatz M, Grieshaber R, Kleesz P, et al. Additive impairment of the barrier function and irritation by biogenic amines and sodium lauryl sulphate: a controlled in vivo tandem irritation study. Skin Pharmacol Physiol. 2005;18(2):88\u201397.","journal-title":"Skin Pharmacol Physiol"},{"issue":"3","key":"3687_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/15287399109531485","volume":"32","author":"I Guest","year":"1991","unstructured":"Guest I, Varma DR. Developmental toxicity of methylamines in mice. J Toxicol Environ Health. 1991;32(3):319\u201330.","journal-title":"J Toxicol Environ Health"},{"issue":"1","key":"3687_CR31","first-page":"1","volume":"17","author":"W Friemann","year":"1959","unstructured":"Friemann W, Overhoff W, Wolter JR. Eye diseases in the fishing industry. Arch Gewerbepathol Gewerbehyg. 1959;17(1):1\u201356.","journal-title":"Arch Gewerbepathol Gewerbehyg"},{"issue":"886","key":"3687_CR32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/pgmj.75.886.451","volume":"75","author":"HU Rehman","year":"1999","unstructured":"Rehman HU. Fish odor syndrome. Postgrad Med J. 1999;75(886):451\u20132.","journal-title":"Postgrad Med J"},{"key":"3687_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nut.2018.03.004","volume":"54","author":"K Bielinska","year":"2018","unstructured":"Bielinska K, Radkowski M, Grochowska M, Perlejewski K, Huc T, Jaworska K, et al. High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats. Nutrition. 2018;54:33\u20139.","journal-title":"Nutrition"},{"issue":"1","key":"3687_CR34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156\u20139.","journal-title":"Anal Biochem"},{"issue":"17","key":"3687_CR35","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.3390\/ijms21176161","volume":"21","author":"A Drapala","year":"2020","unstructured":"Drapala A, Szudzik M, Chabowski D, Mogilnicka I, Jaworska K, Kraszewska K, et al. Heart failure disturbs gut-blood barrier and increases plasma trimethylamine, a toxic bacterial metabolite. Int J Mol Sci. 2020;21(17):6161.","journal-title":"Int J Mol Sci."},{"key":"3687_CR36","first-page":"301","volume":"20","author":"P Gatarek","year":"2021","unstructured":"Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health. EXCLI J. 2021;20:301\u201319.","journal-title":"EXCLI J"},{"key":"3687_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-nutr-071816-064732","volume":"37","author":"SH Zeisel","year":"2017","unstructured":"Zeisel SH, Warrier M. Trimethylamine N-Oxide, the microbiome, and heart and kidney disease. Annu Rev Nutr. 2017;37:157\u201381.","journal-title":"Annu Rev Nutr"},{"issue":"30","key":"3687_CR38","doi-asserted-by":"publisher","first-page":"9101","DOI":"10.1021\/bi970247h","volume":"36","author":"A Wang","year":"1997","unstructured":"Wang A, Bolen DW. A naturally occurring protective system in urea-rich cells: mechanism of osmolyte protection of proteins against urea denaturation. Biochemistry. 1997;36(30):9101\u20138.","journal-title":"Biochemistry"},{"issue":"4","key":"3687_CR39","first-page":"371","volume":"50","author":"PH Yancey","year":"2004","unstructured":"Yancey PH, Rhea MD, Kemp KM, Bailey DM. Trimethylamine oxide, betaine and other osmolytes in deep-sea animals: depth trends and effects on enzymes under hydrostatic pressure. Cell Mol Biol (Noisy-le-grand). 2004;50(4):371\u20136.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"5 Pt 2","key":"3687_CR40","first-page":"F847","volume":"259","author":"T Moriyama","year":"1990","unstructured":"Moriyama T, Garcia-Perez A, Burg MB. Factors affecting the ratio of different organic osmolytes in renal medullary cells. Am J Physiol. 1990;259(5 Pt 2):F847\u201358.","journal-title":"Am J Physiol"},{"issue":"3 Pt 2","key":"3687_CR41","first-page":"F472","volume":"264","author":"T Nakanishi","year":"1993","unstructured":"Nakanishi T, Uyama O, Nakahama H, Takamitsu Y, Sugita M. Determinants of relative amounts of medullary organic osmolytes: effects of NaCl and urea differ. Am J Physiol. 1993;264(3 Pt 2):F472\u20139.","journal-title":"Am J Physiol"},{"issue":"2 Pt 2","key":"3687_CR42","first-page":"R669","volume":"273","author":"DL Sackett","year":"1997","unstructured":"Sackett DL. Natural osmolyte trimethylamine N-oxide stimulates tubulin polymerization and reverses urea inhibition. Am J Physiol. 1997;273(2 Pt 2):R669\u201376.","journal-title":"Am J Physiol"},{"issue":"6","key":"3687_CR43","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1046\/j.1523-1755.2002.00356.x","volume":"61","author":"AX Garg","year":"2002","unstructured":"Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 2002;61(6):2165\u201375.","journal-title":"Kidney Int"},{"issue":"4","key":"3687_CR44","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/bcp.12104","volume":"76","author":"P Cravedi","year":"2013","unstructured":"Cravedi P, Remuzzi G. Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br J Clin Pharmacol. 2013;76(4):516\u201323.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3687_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrcardio.2009.11","volume":"6","author":"V Agrawal","year":"2009","unstructured":"Agrawal V, Marinescu V, Agarwal M, McCullough PA. Cardiovascular implications of proteinuria: an indicator of chronic kidney disease. Nat Rev Cardiol. 2009;6(4):301\u201311.","journal-title":"Nat Rev Cardiol"},{"key":"3687_CR46","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1111\/j.1523-1755.2004.09212.x","volume":"92","author":"J Segura","year":"2004","unstructured":"Segura J, Campo C, Ruilope LM. Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension. Kidney Int Suppl. 2004;92:S45\u20139.","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"3687_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.trre.2010.02.002","volume":"24","author":"W Huo","year":"2010","unstructured":"Huo W, Zhang K, Nie Z, Li Q, Jin F. Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. Transplant Rev (Orlando). 2010;24(3):143\u20136.","journal-title":"Transplant Rev (Orlando)"},{"issue":"1","key":"3687_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/path.2642","volume":"220","author":"F Waanders","year":"2010","unstructured":"Waanders F, van Timmeren MM, Stegeman CA, Bakker SJ, van Goor H. Kidney injury molecule-1 in renal disease. J Pathol. 2010;220(1):7\u201316.","journal-title":"J Pathol"},{"issue":"5","key":"3687_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/0885066618824531","volume":"35","author":"BR Griffin","year":"2020","unstructured":"Griffin BR, Gist KM, Faubel S. Current status of novel biomarkers for the diagnosis of acute kidney injury: a historical perspective. J Intensive Care Med. 2020;35(5):415\u201324.","journal-title":"J Intensive Care Med"},{"key":"3687_CR50","doi-asserted-by":"publisher","first-page":"39372","DOI":"10.1038\/srep39372","volume":"6","author":"CC Hung","year":"2016","unstructured":"Hung CC, Lin HY, Lee JJ, Lim LM, Chiu YW, Chiang HP, et al. Glycosuria and renal outcomes in patients with nondiabetic advanced chronic kidney disease. Sci Rep. 2016;6:39372.","journal-title":"Sci Rep"},{"issue":"3","key":"3687_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1067\/mlc.2003.21","volume":"141","author":"MC Hsieh","year":"2003","unstructured":"Hsieh MC, Wu CH, Chen CL, Chen HC, Chang CC, Shin SJ. High blood glucose and osmolality, but not high urinary glucose and osmolality, affect neuronal nitric oxide synthase expression in diabetic rat kidney. J Lab Clin Med. 2003;141(3):200\u20139.","journal-title":"J Lab Clin Med"},{"issue":"1","key":"3687_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144640","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Thai K, Kepecs DM, Gilbert RE. Sodium-glucose linked cotransporter-2 inhibition does not attenuate disease progression in the rat remnant kidney model of chronic kidney disease. PLoS ONE. 2016;11(1): e0144640.","journal-title":"PLoS ONE"},{"issue":"5","key":"3687_CR53","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.amjms.2016.08.015","volume":"352","author":"L Chen","year":"2016","unstructured":"Chen L, LaRocque LM, Efe O, Wang J, Sands JM, Klein JD. Effect of dapagliflozin treatment on fluid and electrolyte balance in diabetic rats. Am J Med Sci. 2016;352(5):517\u201323.","journal-title":"Am J Med Sci"},{"issue":"3 Suppl","key":"3687_CR54","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1293\/tox.29.3S-1","volume":"29","author":"BR Berridge","year":"2016","unstructured":"Berridge BR, Mowat V, Nagai H, Nyska A, Okazaki Y, Clements PJ, et al. Non-proliferative and proliferative lesions of the cardiovascular system of the rat and mouse. J Toxicol Pathol. 2016;29(3 Suppl):1S-47S.","journal-title":"J Toxicol Pathol"},{"issue":"4","key":"3687_CR55","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1080\/10408440802368642","volume":"39","author":"GC Hard","year":"2009","unstructured":"Hard GC, Johnson KJ, Cohen SM. A comparison of rat chronic progressive nephropathy with human renal disease-implications for human risk assessment. Crit Rev Toxicol. 2009;39(4):332\u201346.","journal-title":"Crit Rev Toxicol"},{"issue":"10","key":"3687_CR56","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1038\/sj.ki.5000350","volume":"69","author":"K Kawamura","year":"2006","unstructured":"Kawamura K, Okada S, Li B, Suwa M, Yao J, Morioka T, et al. Turbulence of glomerular hemodynamics involved in progressive glomerulosclerosis. Kidney Int. 2006;69(10):1792\u20138.","journal-title":"Kidney Int"},{"issue":"6","key":"3687_CR57","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11886-006-0098-7","volume":"8","author":"YM Barri","year":"2006","unstructured":"Barri YM. Hypertension and kidney disease: a deadly connection. Curr Cardiol Rep. 2006;8(6):411\u20137.","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"3687_CR58","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semnephrol.2005.02.008","volume":"25","author":"M Wiederkehr","year":"2005","unstructured":"Wiederkehr M, Toto R, Fenves AZ, Ram CV. Hypertension and the kidney. Semin Nephrol. 2005;25(4):236\u201345.","journal-title":"Semin Nephrol"},{"issue":"1","key":"3687_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM199601043340103","volume":"334","author":"MJ Klag","year":"1996","unstructured":"Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334(1):13\u20138.","journal-title":"N Engl J Med"},{"issue":"5","key":"3687_CR60","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/hmg\/7.5.839","volume":"7","author":"EP Treacy","year":"1998","unstructured":"Treacy EP, Akerman BR, Chow LM, Youil R, Bibeau C, Lin J, et al. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Hum Mol Genet. 1998;7(5):839\u201345.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"3687_CR61","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/BF00692570","volume":"158","author":"RP Charest","year":"1988","unstructured":"Charest RP, Chenoweth M, Dunn A. Metabolism of trimethylamines in kelp bass (Paralabrax clathratus) and marine and freshwater pink salmon (Oncorhynchus gorbuscha). J Comp Physiol B. 1988;158(5):609\u201319.","journal-title":"J Comp Physiol B"},{"issue":"1","key":"3687_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2307\/1543162","volume":"196","author":"RH Kelly","year":"1999","unstructured":"Kelly RH, Yancey PH. High contents of trimethylamine oxide correlating with depth in deep-sea teleost fishes, skates, and decapod crustaceans. Biol Bull. 1999;196(1):18\u201325.","journal-title":"Biol Bull"},{"issue":"1","key":"3687_CR63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cbpb.2004.02.002","volume":"138","author":"S Sadok","year":"2004","unstructured":"Sadok S, M\u2019Hetli M, El Abed A, Uglow RF. Changes in some nitrogenous compounds in the blood and tissues of freshwater pikeperch (Sander lucioperca) during salinity acclimation. Comp Biochem Physiol A Mol Integr Physiol. 2004;138(1):9\u201315.","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"issue":"4","key":"3687_CR64","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jez.a.140","volume":"303","author":"JR Treberg","year":"2005","unstructured":"Treberg JR, Bystriansky JS, Driedzic WR. Temperature effects on trimethylamine oxide accumulation and the relationship between plasma concentration and tissue levels in smelt (Osmerus mordax). J Exp Zool A Comp Exp Biol. 2005;303(4):283\u201393.","journal-title":"J Exp Zool A Comp Exp Biol"},{"issue":"2","key":"3687_CR65","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/0003-2697(90)90449-J","volume":"187","author":"KA daCosta","year":"1990","unstructured":"daCosta KA, Vrbanac JJ, Zeisel SH. The measurement of dimethylamine, trimethylamine, and trimethylamine N-oxide using capillary gas chromatography-mass spectrometry. Anal Biochem. 1990;187(2):234\u20139.","journal-title":"Anal Biochem"},{"issue":"4","key":"3687_CR66","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000513033","volume":"46","author":"J Zhou","year":"2021","unstructured":"Zhou J, Wang D, Li B, Li X, Lai X, Lei S, et al. Relationship between plasma trimethylamine N-oxide levels and renal dysfunction in patients with hypertension. Kidney Blood Press Res. 2021;46(4):421\u201332.","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"3687_CR67","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ab.2004.07.004","volume":"334","author":"MA Bain","year":"2004","unstructured":"Bain MA, Faull R, Fornasini G, Milne RW, Schumann R, Evans AM. Quantifying trimethylamine and trimethylamine-N-oxide in human plasma: interference from endogenous quaternary ammonium compounds. Anal Biochem. 2004;334(2):403\u20135.","journal-title":"Anal Biochem"},{"issue":"4","key":"3687_CR68","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1080\/09637486.2016.1256379","volume":"68","author":"AM Malinowska","year":"2017","unstructured":"Malinowska AM, Szwengiel A, Chmurzynska A. Dietary, anthropometric, and biochemical factors influencing plasma choline, carnitine, trimethylamine, and trimethylamine-N-oxide concentrations. Int J Food Sci Nutr. 2017;68(4):488\u201395.","journal-title":"Int J Food Sci Nutr"},{"issue":"10","key":"3687_CR69","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/00498250110065586","volume":"31","author":"IP Nnane","year":"2001","unstructured":"Nnane IP, Damani LA. Pharmacokinetics of trimethylamine in rats, including the effects of a synthetic diet. Xenobiotica. 2001;31(10):749\u201355.","journal-title":"Xenobiotica"},{"issue":"8","key":"3687_CR70","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0006-2952(98)00218-4","volume":"56","author":"DH Lang","year":"1998","unstructured":"Lang DH, Yeung CK, Peter RM, Ibarra C, Gasser R, Itagaki K, et al. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3. Biochem Pharmacol. 1998;56(8):1005\u201312.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"3687_CR71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1006\/abbi.2001.2317","volume":"391","author":"V Lattard","year":"2001","unstructured":"Lattard V, Buronfosse T, Lachuer J, Longin-Sauvageon C, Moulin C, Benoit E. Cloning, sequencing, tissue distribution, and heterologous expression of rat flavin-containing monooxygenase 3. Arch Biochem Biophys. 2001;391(1):30\u201340.","journal-title":"Arch Biochem Biophys"},{"issue":"8","key":"3687_CR72","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0006-2952(02)00886-9","volume":"63","author":"V Lattard","year":"2002","unstructured":"Lattard V, Lachuer J, Buronfosse T, Garnier F, Benoit E. Physiological factors affecting the expression of FMO1 and FMO3 in the rat liver and kidney. Biochem Pharmacol. 2002;63(8):1453\u201364.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"3687_CR73","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1124\/jpet.109.152058","volume":"329","author":"RM Novick","year":"2009","unstructured":"Novick RM, Mitzey AM, Brownfield MS, Elfarra AA. Differential localization of flavin-containing monooxygenase (FMO) isoforms 1, 3, and 4 in rat liver and kidney and evidence for expression of FMO4 in mouse, rat, and human liver and kidney microsomes. J Pharmacol Exp Ther. 2009;329(3):1148\u201355.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"3687_CR74","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1210\/en.2008-1795","volume":"150","author":"MI Chiamolera","year":"2009","unstructured":"Chiamolera MI, Wondisford FE. Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology. 2009;150(3):1091\u20136.","journal-title":"Endocrinology"},{"issue":"1","key":"3687_CR75","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4149\/endo_2013_01_39","volume":"47","author":"I Herichova","year":"2013","unstructured":"Herichova I, Szantoova K. Renin-angiotensin system: upgrade of recent knowledge and perspectives. Endocr Regul. 2013;47(1):39\u201352.","journal-title":"Endocr Regul"},{"issue":"1","key":"3687_CR76","first-page":"F62","volume":"235","author":"AJ Naftilan","year":"1978","unstructured":"Naftilan AJ, Oparil S. Inhibition of renin release from rat kidney slices by the angiotensins. Am J Physiol. 1978;235(1):F62\u20138.","journal-title":"Am J Physiol"},{"key":"3687_CR77","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fendo.2012.00052","volume":"3","author":"S Radovick","year":"2012","unstructured":"Radovick S, Levine JE, Wolfe A. Estrogenic regulation of the GnRH neuron. Front Endocrinol (Lausanne). 2012;3:52.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3687_CR78","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/01.RES.72.2.312","volume":"72","author":"H Schunkert","year":"1993","unstructured":"Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, et al. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res. 1993;72(2):312\u20138.","journal-title":"Circ Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03687-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03687-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03687-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T23:08:53Z","timestamp":1701212933000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03687-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3687"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03687-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"assertion":[{"value":"10 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed according to Directive 1020\/63 EU on the protection of animals used for scientific purposes and approved by the II Local Ethical Committee in Warsaw (permission: WAW2\/098\/2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"470"}}